ǿմý

Mariana C. Baserga
No Rating Available
(Learn About Our Rating System)

Mariana C. Baserga, MD

Languages spoken: Italian, Spanish, French, English

Clinical Locations

Intermountain Medical Center

Murray
801-507-7000

Primary Children's Hospital

Newborn Intensive Care Unit
Salt Lake City
801-662-4100

University of Utah Hospital

Newborn Intensive Care Unit
Salt Lake City
801-581-2745

  • “Mariana Baserga, M.D. is a Professor in the Division of Neonatology at the University of Utah, School of Medicine. She received her pediatrics trianing both in Buenos Aires, Argentina and then at Childrens Hospital in Orange County, CA. She completed her Neonatology training at Cedars Sinai Medical Center and UCLA in Los Angeles, CA. She joined the University of Utah in 2004. She provides neonatology services at three facilities, the Neonatal Intensive Care Unit (NICU) at University of Utah Hospital where she is the current Medical Director, Primary Children’s Hospital and Intermountain Medical Center. Among her responsibilities is educating Pediatric Residents, Neonatology Fellows and Neonatal Nurse Practitioners.”

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

  • “Mariana Baserga, M.D. is a Professor in the Division of Neonatology at the University of Utah, School of Medicine. She received her pediatrics trianing both in Buenos Aires, Argentina and then at Childrens Hospital in Orange County, CA. She completed her Neonatology training at Cedars Sinai Medical Center and UCLA in Los Angeles, CA. She joined the University of Utah in 2004. She provides neonatology services at three facilities, the Neonatal Intensive Care Unit (NICU) at University of Utah Hospital where she is the current Medical Director, Primary Children’s Hospital and Intermountain Medical Center. Among her responsibilities is educating Pediatric Residents, Neonatology Fellows and Neonatal Nurse Practitioners.”

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Neonatology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

    Education history

    Residency Pediatrics - Children's Hospital - Orange County Resident
    Fellowship Neonatology - Cedars - Sinai Medical Center Fellow
    Fellowship Cedars - Sinai Medical Center Fellow
    Fellowship Cardiovascular Research - University of California - San Francisco Fellow
    Residency Pediatrics - Hospital Britanico de Buenos Aires Resident
    Professional Medical Medicine - Universidad del Salvador M.D.
    Undergraduate Colegio Esclavas del Sagrado Corazon de Jesus B.A.

    Selected Publications

    Journal Article

    1. Rasmussen MIS, Hansen ML, Peters C, Greisen G, SafeBoosC-III Trial Group (2024). Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-III. Trials, 25(1), 711. ()
    2. Merhar SL, Hu Z, Devlin LA, Ounpraseuth ST, Simon AE, Smith PB, Walsh MC, Lee JY, Das A, Higgins RD, Crawford MM, Rice W, Paul DA, Maxwell JR, Telang SD, Fung CM, Wright T, Reynolds AM, Hahn D, Ross J, McAllister JM, Crowley M, Shaikh SK, Christ L, Brown J, Riccio J, Wong Ramsey K, Braswell EF, Tucker L, McAlmon K, Dummula K, Weiner J, White JR, Howell MP, Newman S, Snowden JN, Young LW, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network National Institutes of ǿմý Environmental Influences on Child ǿմý Outcomes Program Institutional Development Award States Pediatric Clinical Tri, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network National Institutes of ǿմý Environmental Influences on Child ǿմý Outcomes Program Institutional Development Award States Pediatric Clinical Trials Network (2025). Infant Feeding and Weight Trajectories in the Eat, Sleep, Console Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr, 178(10), 976-984. ()
    3. Speer AL, Lally KP, Pedroza C, Zhang Y, Poindexter BB, Chwals WJ, Hintz SR, Besner GE, Stevenson DK, Ohls RK, Truog WE, Stoll BJ, Rysavy MA, Das A, Tyson JE, Blakely ML, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2024). Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation Lead to Severe Growth Failure in Infants. Ann Surg, 280(3), 432-443. ()
    4. Bahr TM, Tan S, Smith E, Beauman SS, Schibler KR, Grisby CA, Lowe JR, Bell EF, Laptook AR, Shankaran S, Carlton DP, Rau C, Baserga MC, Flibotte J, Zaterka-Baxter K, Walsh MC, Das A, Christensen RD, Ohls RK, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2023). Serum ferritin values in neonates <29 weeks' gestation are highly variable and do not correlate with reticulocyte hemoglobin content. J Perinatol, 43(11), 1368-1373. ()
    5. Jensen EA, Wiener LE, Rysavy MA, Dysart KC, Gantz MG, Eichenwald EC, Greenberg RG, Harmon HM, Laughon MM, Watterberg KL, Walsh MC, Yoder BA, Lorch SA, DeMauro SB, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2023). Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants. JAMA Netw Open, 6(5), e2312277. ()
    6. Brumbaugh JE, Vohr BR, Bell EF, Bann CM, Travers CP, McGowan EC, Harmon HM, Carlo WA, Duncan AF, Hintz SR, Eunice Kennedy Shriver NICHD Neonatal Research Network (2023). Early-Life Outcomes in Relation to Social Determinants of ǿմý for Children Born Extremely Preterm. J Pediatr, 113443. ()
    7. Hansen ML, Pellicer A, Hyttel-Srensen S, Ergenekon E, Szczapa T, Hagmann C, Naulaers G, Mintzer J, Fumagalli M, Dimitriou G, Dempsey E, Tkaczyk J, Cheng G, Fredly S, Heuchan AM, Pichler G, Fuchs H, Nesargi S, Hahn GH, Piris-Borregas S, irc J, Alsina-Casanova M, Stocker M, Ozkan H, Sarafidis K, Hopper AO, Karen T, Rzepecka-Weglarz B, Oguz SS, Arruza L, Memisoglu AC, Del Rio Florentino R, Baserga M, Maton P, Truttmann AC, de Las Cuevas I, Agergaard P, Zafra P, Bender L, Lauterbach R, Lecart C, de Buyst J, El-Khuffash A, Curley A, Vaccarello OO, Miletin J, Papathoma E, Vesoulis Z, Vento G, Cornette L, Lopez LS, Yasa B, Klamer A, Agosti M, Baud O, Mastretta E, Cetinkaya M, McCall K, Zeng S, Hatzidaki E, Bargiel A, Marciniak S, Gao X, Huijia L, Chalak L, Yang L, Rao SA, Xu X, Gonzalez BL, Wilinska M, Yin Z, Sadowska-Krawczenko I, Serrano-Viuales I, Krolak-Olejnik B, Ybarra MM, Morales-Betancourt C, Korek P, Teresa-Palacio M, Mosca F, Hergenhan A, Koksal N, Tsoni K, Kadri MM, Knpfli C, Rafinska-Wazny E, Akin MS, Nordvik T, Peng Z, Kersin SG, Thewissen L, Alarcon A, Healy D, Urlesberger B, Ba M, Baumgartner J, Skylogianni E, Karadyova V, Valverde E, Bergon-Sendin E, Kucera J, Pisoni S, Wang L, Smits A, Sanchez-Salmador R, Rasmussen MI, Olsen MH, Jensen AK, Gluud C, Jakobsen JC, Greisen G (2023). Cerebral Oximetry Monitoring in Extremely Preterm Infants. N Engl J Med, 388(16), 1501-1511. ()
    8. Garcia MR, Comstock BA, Patel RM, Tolia VN, Josephson CD, Georgieff MK, Rao R, Monsell SE, Juul SE, Ahmad KA, PENUT Trial Consortium (2022). Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns. Pediatr Res, 93(3), 701-707. ()
    9. Hudak ML, Flannery DD, Barnette K, Getzlaff T, Gautam S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Ellington SR, Galang RR, Snead MC, Woodworth KR, Zapata LB, Puopolo KM, AMERICAN ACADEMY OF PEDIATRICS NPC-19 REGISTRY INVESTIGATORS (2022). Maternal and Newborn Hospital Outcomes of Perinatal SARS-CoV-2 Infection: A National Registry. Pediatrics, 151(2). ()
    10. Juul SE, Wood TR, German K, Law JB, Kolnik SE, Puia-Dumitrescu M, Mietzsch U, Gogcu S, Comstock BA, Li S, Mayock DE, Heagerty PJ, PENUT Consortium (2022). Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches. EClinicalMedicine, 56, 101782. ()
    11. Brumbaugh JE, Bell EF, Do BT, Greenberg RG, Stoll BJ, DeMauro SB, Harmon HM, Hintz SR, Das A, Puopolo KM, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2022). Incidence of and Neurodevelopmental Outcomes After Late-Onset Meningitis Among Children Born Extremely Preterm. JAMA Netw Open, 5(12), e2245826. ()
    12. Chawla S, Wyckoff MH, Rysavy MA, Patel RM, Chowdhury D, Natarajan G, Laptook AR, Lakshminrusimha S, Bell EF, Shankaran S, Van Meurs KP, Ambalavanan N, Greenberg RG, Younge N, Werner EF, Das A, Carlo WA, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2022). Association of Antenatal Steroid Exposure at 21 to 22 Weeks of Gestation With Neonatal Survival and Survival Without Morbidities. JAMA Netw Open, 5(9), e2233331. ()
    13. Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, Mathur AM, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Poindexter BB, Rogers EE, Lowe JR, Kuban KCK, OShea TM, Wisnowski JL, McKinstry RC, Bluml S, Bonifacio S, Benninger KL, Rao R, Smyser CD, Sokol GM, Merhar S, Schreiber MD, Glass HC, Heagerty PJ, Juul SE, HEAL Consortium (2022). Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med, 387(2), 148-159. ()
    14. Askenazi DJ, Halloran BA, Heagerty PJ, Schmicker RH, Brophy P, Juul SE, Hingorani S, Goldstein SL, PENUT Trial Consortium (2021). Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates. Pediatr Res, 92(1), 151-167. ()
    15. Bahr TM, Ohls RK, Baserga MC, Lawrence SM, Winter SL, Christensen RD (2022). Implications of an Elevated Nucleated Red Blood Cell Count in Neonates with Moderate to Severe Hypoxic-Ischemic Encephalopathy. J Pediatr, 246, 12-18.e2. ()
    16. Gentle SJ, Carper B, Laughon MM, Jensen EA, Williams A, Travers CP, Ambalavanan N, Lal CV, Carlo WA (2022). Duration of noninvasive respiratory support and risk for bronchopulmonary dysplasia or death. J Perinatol, 42(4), 454-460. ()
    17. Watterberg KL, Walsh MC, Li L, Chawla S, DAngio CT, Goldberg RN, Hintz SR, Laughon MM, Yoder BA, Kennedy KA, McDavid GE, Backstrom-Lacy C, Das A, Crawford MM, Keszler M, Sokol GM, Poindexter BB, Ambalavanan N, Hibbs AM, Truog WE, Schmidt B, Wyckoff MH, Khan AM, Garg M, Chess PR, Reynolds AM, Moallem M, Bell EF, Meyer LR, Patel RM, Van Meurs KP, Cotten CM, McGowan EC, Hines AC, Merhar S, Peralta-Carcelen M, Wilson-Costello DE, Kilbride HW, DeMauro SB, Heyne RJ, Mosquera RA, Natarajan G, Purdy IB, Lowe JR, Maitre NL, Harmon HM, Hogden LA, Adams-Chapman I, Winter S, Malcolm WF, Higgins RD, Eunice Kennedy Shriver NICHD Neonatal Research Network (2022). Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. N Engl J Med, 386(12), 1121-1131. ()
    18. Flibotte J, Laptook AR, Shankaran S, McDonald SA, Baserga MC, Bell EF, Cotten CM, Das A, DeMauro SB, DuPont TL, Eichenwald EC, Heyne R, Jensen EA, Van Meurs KP, Dysart K, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2022). Blanket temperature during therapeutic hypothermia and outcomes in hypoxic ischemic encephalopathy. J Perinatol, 42(3), 348-353. ()
    19. Puia-Dumitrescu M, Wood TR, Comstock BA, Law JB, German K, Perez KM, Gogcu S, Mayock DE, Heagerty PJ, Juul SE, Preterm Erythropoietin Neuroprotection PENUT Trial Consortium (2022). Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants. JAMA Netw Open, 5(3), e221947. ()
    20. Juul SE, Wood TR, Comstock BA, Perez K, Gogcu S, Puia-Dumitrescu M, Berkelhamer S, Heagerty PJ, PENUT Consortium (2022). Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial. JAMA Netw Open, 5(2), e2146404. ()
    21. Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, Walsh MC, Vohr BR, Stoll BJ, Carlo WA, Van Meurs KP, Rysavy MA, Patel RM, Merhar SL, Snchez PJ, Laptook AR, Hibbs AM, Cotten CM, DAngio CT, Winter S, Fuller J, Das A, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2022). Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA, 327(3), 248-263. ()
    22. Bushati C, Chan B, Harmeson Owen A, Woodbury A, Yang M, Fung C, Lechtenberg E, Rigby M, Baserga M (2021). Challenges in Implementing Exclusive Human Milk Diet to Extremely Low-Birth-Weight Infants in a Level III Neonatal Intensive Care Unit. Nutr Clin Pract, 36(6), 1198-1206. ()
    23. Mayock DE, Gogcu S, Puia-Dumitrescu M, Shaw DWW, Wright JN, Comstock BA, Heagerty PJ, Juul SE, Preterm Erythropoietin Neuroprotection PENUT Trial Consortium (2021). Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort. J Pediatr, 239, 117-125.e6. ()
    24. German KR, Vu PT, Comstock BA, Ohls RK, Heagerty PJ, Mayock DE, Georgieff M, Rao R, Juul SE, PENUT Consortium (2021). Enteral Iron Supplementation in Infants Born Extremely Preterm and its Positive Correlation with Neurodevelopment; Post Hoc Analysis of the Preterm Erythropoietin Neuroprotection Trial Randomized Controlled Trial. J Pediatr, 238, 102-109.e8. ()
    25. Chalak L, Redline RW, Goodman AM, Juul SE, Chang T, Yanowitz TD, Maitre N, Mayock DE, Lampland AL, Bendel-Stenzel E, Riley D, Mathur AM, Rao R, Van Meurs KP, Wu TW, Gonzalez FF, Flibotte J, Mietzsch U, Sokol GM, Ahmad KA, Baserga M, Weitkamp JH, Poindexter BB, Comstock BA, Wu YW (2021). Acute and Chronic Placental Abnormalities in a Multicenter Cohort of Newborn Infants with Hypoxic-Ischemic Encephalopathy. J Pediatr, 237, 190-196. ()
    26. Wood TR, Parikh P, Comstock BA, Law JB, Bammler TK, Kuban KC, Mayock DE, Heagerty PJ, Juul S, PENUT Trial consortium (2021). Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial. EBioMedicine, 72, 103605. ()
    27. Olsen MH, Hansen ML, Safi S, Jakobsen JC, Greisen G, Gluud C, SafeBoosC-III Trial Group (2021). Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach. BMC Med Res Methodol, 21(1), 160. ()
    28. Vu PT, Ohls RK, Mayock DE, German KR, Comstock BA, Heagerty PJ, Juul SE, PENUT Consortium (2021). Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial. Pediatr Res, 90(1), 109-116. ()
    29. Puia-Dumitrescu M, Comstock BA, Li S, Heagerty PJ, Perez KM, Law JB, Wood TR, Gogcu S, Mayock DE, Juul SE, PENUT Consortium (2021). Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines. JAMA Netw Open, 4(7), e2115998. ()
    30. DuPont TL, Baserga M, Lowe J, Zamora T, Beauman S, Ohls RK (2021). Darbepoetin as a neuroprotective agent in mild neonatal encephalopathy: a randomized, placebo-controlled, feasibility trial. J Perinatol, 41(6), 1339-1346. ()
    31. Kumbhat N, Eggleston B, Davis AS, DeMauro SB, Van Meurs KP, Foglia EE, Lakshminrusimha S, Walsh MC, Watterberg KL, Wyckoff MH, Das A, Handley SC, Generic Database Subcommittee of the National Institute of Child ǿմý and Human Development Neonatal Research Network (2021). Umbilical Cord Milking vs Delayed Cord Clamping and Associations with In-Hospital Outcomes among Extremely Premature Infants. J Pediatr, 232, 87-94.e4. ()
    32. Askenazi DJ, Heagerty PJ, Schmicker RH, Brophy P, Juul SE, Goldstein SL, Hingorani S, PENUT Trial Consortium (2021). The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial. J Pediatr, 232, 65-72.e7. ()
    33. Wisnowski JL, Bluml S, Panigrahy A, Mathur AM, Berman J, Chen PK, Dix J, Flynn T, Fricke S, Friedman SD, Head HW, Ho CY, Kline-Fath B, Oveson M, Patterson R, Pruthi S, Rollins N, Ramos YM, Rampton J, Rusin J, Shaw DW, Smith M, Tkach J, Vasanawala S, Vossough A, Whitehead MT, Xu D, Yeom K, Comstock B, Heagerty PJ, Juul SE, Wu YW, McKinstry RC, HEAL Study Group (2021). Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation. BMJ Open, 11(4), e043852. ()
    34. Stoll BJ, Puopolo KM, Hansen NI, Snchez PJ, Bell EF, Carlo WA, Cotten CM, DAngio CT, Kazzi SNJ, Poindexter BB, Van Meurs KP, Hale EC, Collins MV, Das A, Baker CJ, Wyckoff MH, Yoder BA, Watterberg KL, Walsh MC, Devaskar U, Laptook AR, Sokol GM, Schrag SJ, Higgins RD, Eunice Kennedy Shriver National Institute of Child ǿմý and Human Development Neonatal Research Network (2020). Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr, 174(7), e200593. ()
    35. Sandra E Juul1, Bryan A Comstock1, Rajan Wadhawan2 Dennis E Mayock1, Sherry E Courtney3, Tonya Robinson4, Kaashif A Ahmad5, Ellen Bendel-Stenzel6, Mariana Baserga7, Edmund F LaGamma8, L Corbin Downey9, Raghavendra Rao10, Nancy Fahim10, Andrea Lampland11, Ivan D Frantz, III12, Janine Y Khan13, Michael Weiss14, Maureen M Gilmore15, Robin K Ohls16, Nishant Srinivasan17, Jorge E Perez18, Victor McKay19, Phuong T Vu1, Jean Lowe16, Karl Kuban20 Michael OShea21, Adam L Hartman22, Patrick J Heagerty1, and the PENUT Trial Consortium (2020). Safety and Efficacy of High Dose Erythropoietin Administered Prophylactically to Extremely Low Gestational Age Neonates in the Preterm Epo Neuroprotection (PENUT) Trial. N Engl J Med.
    36. Braski K, Weaver-Lewis K, Loertscher M, Ding Q, Sheng X, Baserga M (2017). Splanchnic-Cerebral Oxygenation Ratio Decreases during Enteral Feedings in Anemic Preterm Infants: Observations under Near-Infrared Spectroscopy. Neonatology, 113(1), 75-80. ()
    37. Baserga M, Chan B (2018). Hematochezia and thrombocytopenia in a 3-day-old infant: Congenital adenoviral infection. J Neonatal Perinatal Med, 11(3), 335-338. ()
    38. Baserga M, Kaur R, Hale MA, Bares A, Yu X, Callaway CW, McKnight RA, Lane RH (2010). Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. Am J Physiol Regul Integr Comp Physiol, 299(1), R334-42. ()
    39. Baserga M, Bares AL, Hale MA, Callaway CW, McKnight RA, Lane PH, Lane RH (2009). Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension. Early Hum Dev, 85(6), 361-7. ()
    40. Baserga M, Hale MA, Ke X, Wang ZM, Yu X, Callaway CW, McKnight RA, Lane RH (2006). Uteroplacental insufficiency increases p53 phosphorylation without triggering the p53-MDM2 functional circuit response in the IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol, 291(2), R412-8. ()
    41. Baserga M, Hale MA, McKnight RA, Yu X, Callaway CW, Lane RH (2005). Uteroplacental insufficiency alters hepatic expression, phosphorylation, and activity of the glucocorticoid receptor in fetal IUGR rats. Am J Physiol Regul Integr Comp Physiol, 289(5), R1348-53. ()

    Letter

    1. Bahr TM, Kerry BB, Baserga MC, Christensen RD (2020). Improving thermoregulation in transported preterm infants. [Letter to the editor]. J Perinatol, 41(2), 356-357. ()